Sunday, December 30, 2012 10:15:27 AM
NNVC is getting ready to put out a product.
NNVC is CAREFULLY approaching the US FDA with a new PLATFORM medicine that is new and so NNVC is very careful in each step with the US FDA. Careful.
NNVC has the IV INJECTIBLE FLUCIDE for IMMUNOCOMPROMISED PATIENTS.
NNVC has the ORAL FLUCIDE for higher volume and outpatient cases.
NNVC has the IV FLUCIDE for hospital cases.
That is a lot of research having been done lately by a SMALL COMPANY.
CTIX seemed to speed up progress by going with an already set up company to make their special formula. Saved a lot of time.
Perhaps NNVC is sitting on its tuffet eating its curds and wey, waiting for a big company to see NNVC is making it's own drug laboratory and going alone, and sit down beside it and make an attractrive offer that is maybe 35% or more on a split for FLUCIDE over a very long period.Sort of like POKER only on a larger scale.
There are many pharmaceutical companies that are following the progress of NNVC and they are waiting for NNVC to get past the FDA Clinical Trial One Trial SUCCESSFULY, safe in humans, to move on NNVC. They are watching and the Drs. of NNVC know it.
So on with the show.
Echo20
The Drs.of NNVC have been working on viral cures much longer than has been stated. Many years longer.
NNVC FLUCIDE is their BIG LIFETIME PROJECT nearing fruition.$$$$
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
- Clinical Trial of Broad-Spectrum Antiviral Drug NV-CoV-2 is Progressing Well, Says NanoViricides - NV-CoV-2 is Positioned to Fulfill Many Unmet Medical Needs • InvestorsHub NewsWire • 07/06/2023 03:16:37 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM